Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 10, 2014 - Issue
Submit an article Journal homepage
98
Views
10
CrossRef citations to date
0
Altmetric
Review

Clinical and economic studies of eptifibatide in coronary stenting

Tilak PasalaThe Heart and Vascular Center, Case Western Reserve University/MetroHealth, Cleveland, OH, USA
,
Prasongchai SattayaprasertThe Heart and Vascular Center, Case Western Reserve University/MetroHealth, Cleveland, OH, USA
,
Pradeep K BhatThe Heart and Vascular Center, Case Western Reserve University/MetroHealth, Cleveland, OH, USA
,
Ganesh AthappanThe Heart and Vascular Center, Case Western Reserve University/MetroHealth, Cleveland, OH, USA
&
Sanjay GandhiThe Heart and Vascular Center, Case Western Reserve University/MetroHealth, Cleveland, OH, USACorrespondence[email protected]
Pages 603-614 | Published online: 02 Aug 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bin Wang, Ling Tan, Dengpu Deng, Ting Lu, Changwei Zhou, Zhongkui Li, Zhenjie Tang, Zhongshi Wu & Hao Tang. (2015) Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles. International Journal of Nanomedicine 10, pages 3417-3427.
Read now

Articles from other publishers (9)

M Travis Caton, Kazim H Narsinh, Amanda Baker, Matthew R Amans, Steven W Hetts, Joseph H Rapp, James C Ianuzzi, Elaine Tseng, Warren J Gasper & Daniel L Cooke. (2022) Eptifibatide bridging therapy for staged carotid artery stenting and cardiac surgery: Safety and feasibility. Vascular, pages 170853812210848.
Crossref
C. S. Brian Chia. (2021) A Review on the Metabolism of 25 Peptide Drugs. International Journal of Peptide Research and Therapeutics 27:2, pages 1397-1418.
Crossref
Florian Fischer, Samriddhi Buxy, David J. Kurz, Franz R. Eberli, Oliver Senn, Rainer Zbinden, Ulrike Held & Matthias R. Meyer. (2021) Efficacy and Safety of Abbreviated Eptifibatide Treatment in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. The American Journal of Cardiology 139, pages 15-21.
Crossref
Dermot Cox. (2019) Anti‐platelet agents: past, present and future. ISBT Science Series 15:1, pages 131-141.
Crossref
O. S. Furkalo, D. O. Dziuba, O. A. Loskutov & O. M. Druzina. (2019) Прогностичні фактори тривалості перебування у стаціонарі пацієнтів із гострим коронарним синдромом після екстреної ендоваскулярної реваскуляризації міокарда. Klinicheskaia khirurgiia 85:1, pages 30-34.
Crossref
Katarzyna Pigoń, Edyta Nowak-Radzik, Tomasz Młyńczak, Grzegorz Banasik, Ewa Nowalany-Kozielska & Andrzej Tomasik. (2018) Cost assessment of treatment of acute myocardial infarction and angiographically visible coronary thrombus. Journal of Comparative Effectiveness Research 7:5, pages 471-481.
Crossref
Xiaoqin Zhou, Xinyu Wu, Huan Sun & Jing Li. (2017) Efficacy and safety of eptifibatide versus tirofiban in acute coronary syndrome patients: A systematic review and meta-analysis. Journal of Evidence-Based Medicine 10:2, pages 136-144.
Crossref
Mei Xue, Xuesong Yang, Lin Yang, Na Kou, Yu Miao, Mingming Wang, Junhua Ren & Quanli Zhao. (2017) rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina Patients. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-8.
Crossref
Yingyun Fu, Silong Sun, Jie Liang, Shengguo Liu, Yiqi Jiang, Lan Xu & Junpu Mei. (2016) PEAR1 gene polymorphism in a Chinese pedigree with pulmonary thromboembolism. Medicine 95:51, pages e5687.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.